blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1740198

EP1740198 - ANTI-AGING EFFECTS OF SUBSTANCE P [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.09.2009
Database last updated on 20.07.2024
Most recent event   Tooltip25.09.2009Application deemed to be withdrawnpublished on 28.10.2009  [2009/44]
Applicant(s)For all designated states
ImmuneRegen BioSciences, Inc.
4021 N. 75th Street, Suite 201
Scottsdale, AZ 85251 / US
[2007/02]
Inventor(s)01 / WITTEN, Mark, L.
7032 E. Rosewood Street
Tucson, AZ 85710 / US
 [2007/02]
Representative(s)Tombling, Adrian George, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2007/02]Tombling, Adrian George, et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW / GB
Application number, filing date05755488.318.04.2005
[2007/02]
WO2005US13113
Priority number, dateUS20040565021P26.04.2004         Original published format: US 565021 P
[2007/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005107700
Date:17.11.2005
Language:EN
[2005/46]
Type: A2 Application without search report 
No.:EP1740198
Date:10.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2005 takes the place of the publication of the European patent application.
[2007/02]
Search report(s)International search report - published on:US06.04.2006
(Supplementary) European search report - dispatched on:EP29.01.2009
ClassificationIPC:A61K38/00, A61K38/08, A61P19/02, A61P21/00, A61P27/02, A61P25/28
[2009/09]
CPC:
A61K8/64 (EP,US); A61P19/02 (EP); A61P21/00 (EP);
A61P21/06 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/20 (EP); A61P25/28 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/10 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61Q5/004 (EP,US) (-)
Former IPC [2007/02]A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/02]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ANTI-AGING-WIRKUNG DER SUBSTANZ P[2007/02]
English:ANTI-AGING EFFECTS OF SUBSTANCE P[2007/02]
French:EFFETS ANTI-AGE DE LA SUBSTANCE P[2007/02]
Entry into regional phase27.10.2006National basic fee paid 
27.10.2006Search fee paid 
27.10.2006Designation fee(s) paid 
27.10.2006Examination fee paid 
Examination procedure25.10.2006Amendment by applicant (claims and/or description)
27.10.2006Examination requested  [2007/02]
28.04.2009Application deemed to be withdrawn, date of legal effect  [2009/44]
09.06.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/44]
Fees paidRenewal fee
27.10.2006Renewal fee patent year 03
10.04.2008Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.200905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]  - HOLSBOER F, "The role of peptides in treatment of psychiatric disorders.", JOURNAL OF NEURAL TRANSMISSION SUPPLEMENT, (2003), vol. 64, ISSN 0303-6995, pages 17 - 34, XP009110788 [X] 1 * abstract * [Y] 7-11
 [XY]  - TEGEDER I ET AL, "Release of algesic substances in human experimental muscle pain", INFLAMMATION RESEARCH, (200208), vol. 51, no. 8, ISSN 1023-3830, pages 393 - 402, XP002511071 [X] 2 * abstract * [Y] 1-11

DOI:   http://dx.doi.org/10.1007/PL00000320
 [XY]  - SANTANGELO ERIKA MATTOS ET AL, "Facilitatory effect of substance P on learning and memory in the inhibitory avoidance test for goldfish", NEUROSCIENCE LETTERS, (20010504), vol. 303, no. 2, ISSN 0304-3940, pages 137 - 139, XP002511072 [X] 3 * abstract * [Y] 1-11

DOI:   http://dx.doi.org/10.1016/S0304-3940(01)01698-6
 [XY]  - SASAMOTO M, "IMMUNOHISTOCHEMICAL STUDY OF THE CILIARY GANGLION IN THE GUINEA-PIG", FOLIA OPHTHALMOLOGICA JAPONICA, (1991), vol. 42, no. 11, ISSN 0015-5667, pages 2266 - 2271, XP009110789 [X] 4 * abstract * [Y] 1-11
 [XY]  - LORDAL MIKAEL ET AL, "Tachykinins influence interdigestive rhythm and contractile strength of human small intestine", DIGESTIVE DISEASES AND SCIENCES, (1997), vol. 42, no. 9, ISSN 0163-2116, pages 1940 - 1949, XP002511073 [X] 5 * abstract * [Y] 1-11

DOI:   http://dx.doi.org/10.1023/A:1018875529739
 [XY]  - HONG SEUNG KIL ET AL, "Local neurokinin-1 receptor in the knee joint contributes to the induction, but not maintenance, of arthritic pain in the rat", NEUROSCIENCE LETTERS, (20020329), vol. 322, no. 1, ISSN 0304-3940, pages 21 - 24, XP002511074 [X] 6 * abstract * [Y] 1-11

DOI:   http://dx.doi.org/10.1016/S0304-3940(02)00070-8
International search[A]US2002044925  (LAW PETER K [US]);
 [A]US2002068699  (DONOVAN STEPHEN [US]);
 [A]US2003165541  (DONOVAN STEPHEN [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.